Take a look at the Recent articles

Fear of falling, foot disability and disease activity in patients with rheumatoid arthritis

Bahha J

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Amine B

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

Erraoui M

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

Binoune I EL

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

Boujenane Y

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

Fellous S

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

Rostom S

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

Bahiri R

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, Morocco

DOI: 10.15761/ROM.1000131

Article
Article Info
Author Info
Figures & Data

Abstract

Objective: To evaluate fear of falling (FOF) in patients with established rheumatoid arthritis (RA) and its relationship with disease activity and foot disability.

Materials and methods: A cross-sectional study that included patients with RA. We collected the following data: age, sex, duration of disease, foot pain assessed by the Visual Analogue Scale (VAS), HAQ disability index (HAQ-DI). Disease activity was measured with swollen and tender joint count (SJC28, TJC28), patient and evaluator global assessment of disease activity (PGA, EGA), 28-joint DAS (DAS-28) and the clinical and simple disease activity indexes (CDAI, SDAI). Fear of falling was assessed by Falls Efficacy Scale-International (FES-I). Foot disability was measured using the Leeds Foot Impact Scale (LFIS). Correlations were used to assess the relationship between fear of falling and disease activity, foot pain, impairment and disability. Multiple linear regression analysis was used to explore risk factors associated with FOF.

Results: Thirty-three patients were included. The mean age was 49.3 ± 10.5 years with  female predominance (n = 29 (87.9%)). The mean disease duration was 9.0 ± 7.4 years. The mean VAS foot pain was 5.5 ± 2.4. The mean FES-I score was 37.4 ± 15.1 and 69.7% (n = 23) of patients had  significant fear of falling. FES-I was significantly correlated with foot impairment (r=0.66; p<0.0001) and disability (r=0.80; p <0.0001).

Evaluating the relationship between fear of falling and disease activity, FES-I was significantly correlated with TJC28 (r = 0.52, p = 0.02), PGA (r=0,56, p=0,01), EGA (r=0,39, p=0,025), HAQ-DI (r = 0.70, p = 0001), DAS28 (r = 0, 38, p = 0.029), CDAI (r = 0.48, p = 0.005) and SDAI (r = 0.52, p = 0.002). Foot disability (ß = 0.64 , 95% CI [ 0.36 ; 1.06] , p ≤0.0001) and HAQ-DI (ß= 0.36, 95% CI [1.23 ; 11.80], p =0.017) were  the factors associated with FOF.

Conclusion: This study has demonstrated the importance of the relationship between FOF and disease activity, foot impairment and disability in patients with RA. Others studies are needed to increase the awareness around FOF and foot disability among practitioners.

Key words

fear of falling, foot disability, disease activity, Rheumatoid arthritis

Introduction

Falls are one of the major health care concerns for both older and people with rheumatoid arthritis (RA). Fear of falling (FOF) has been associated with an increased risk of falls in RA patients [1]. The risk of falls may be higher because of gait disorder [2], postural instability [3,4], muscle weakness and lower limb disease [5]. In fact, several studies have demonstrated that the foot is common site of pathology in RA which often results in poor physical functioning due to both structural and functional impairment [6].

However, only few studies have assessed the relationship between FOF and problems related to RA foot such as foot pain disability and impairment.

The aim of the present study is to investigate FOF among patients with RA and to evaluate the relationship between FOF and foot pain, disease activity and foot impairment and disability in patients with established RA.

Materiels and methods

Patients characteristics

Thirty-three participants aged over 18 years old with a history of RA, according to the 2010 ACR/EULAR classification criteria [7], were recruited from the Department of Rheumatology of El Ayachi Hospital, University Hospital of Rabat- Sale, in Morocco. Participants were excluded from the study if they had a history of neuromuscular, cognitive disorders or impaired vision. Participants provided informed written consent.

We collected the following data: age, gender, body mass index (BMI). Clinical characteristics included disease duration, current medications and comorbid conditions. We also obtained the HAQ disability index (HAQ-DI).

Foot pain

A 100 mm visual analogue scale (VAS) was used to measure foot pain in the past week.

Disease activity

The following parameters were evaluated: ESR (mm/h), CRP (mg/l), swollen joint counts (SJC28), tender joint counts (TJC28),  patient global assessment of disease activity [PGA ; visual analogue scale (VAS) 0-10], evaluator global assessment of disease activity [EGA; (VAS) 0-10], patient’s pain assessment (VAS pain 0-10 cm). Composite measures of disease activity: 28-joint DAS (DAS-28) and the clinical and simplified disease activity indexes (CDAI, SDAI) were calculated.

Foot impairment and disability

Patient reported foot disability and impairment were measured using the Leeds Foot Impact Scale (LFIS), a validated measure of the impact of foot disease in RA [8]. Foot disability was represented by the total score (LFIST; range 0 to 51) of the LFIS, foot impairment by the first subscale (LFISIF; range 0 to 21) and activity limitation by the second subscale (LFISAP; range 0–30) [8]. Scores of ≤6 were considered mild, from 7–13 were considered moderate and ≥14 were considered severe for the FISIF [9].

Fear of falling

Fear of falling was assessed using the Falls Efficacy Scale- International (FES-I) [10]. The FES-I measures participants’ level of concern pertaining to falling during physical and social activities, both inside and outside the home, regardless of whether the participant can perform the activity [10]. The FES-I consists of 16 different activities, scored using a four-point scale (1=not at all concerned, 2=somewhat concerned, 3=fairly concerned and 4=very concerned). The summed scores for the 16 activities for each participant were calculated. Scores of ≥23 indicated a high concern of falling [10].

Statistical analysis

Descriptive statistics for clinical and demographic characteristics were obtained. All variables were tested for normality by the Kolmogorov-Smirnov statistic. To evaluate the relationship between fear of falling and foot pain, impairment, disability and disease activity, Pearson’s r-correlation tests were conducted. Multiple linear regression analysis was used to explore risk factors associated with FOF. P<0.05 was acknowledged to be statistically significant level.

All data was analyzed using Statistical Package for the Social Sciences (SPSS) version 21 (IBM, New York, US).

Results

Patients characteristics

Thirty-three patients with RA participated in this study. The demographic features and the disease activity parameters of the patients are shown in table 1.

Table 1 : Clinical characteristics of patients

Parameter

value

Age (years)

49 (24-68)

Female, % (n)

87,9 (29)

Body Mass Index (kg/m2)

26 (16-38)

Disease duration (years), mean (SD)

9 (7.49) (1-36)

Anti-CCP antibodies positive, n (%)

63,6 (21)

Rheumatoid factor positive, n (%)

63,6 (21)

HAQ-DI

1,37 (0.8) (0-2,60)

CDAI

29,9 (13,6) (4-61)

SDAI

31,6 (13,7) (4.4-61.5)

DAS-28

5,5 (1,3) (2,2-7,3)

SJC28

5 (4) (0-17)

TJC28

12 (8) (0-27)

CRP, mg/l

16.7 (18) (0.2-94)

ESR, mm/h

35 (23) (3-90)

PGA, cm

6.2 (2.1) (0-9)

EGA, cm

5.7 (1.7) (0-9)

VAS foot pain

5.5 (2.4) (0-8)

Co-morbid conditions, n (%)

Diabete

9.1 (3)

Heart disease

3 (1)

Hypertension

12.1 (4)

Osteoporosis

33.3 (11)

Renal disease

0

Medications, n (%):

Methotrexate

97 (32)

Biologics

39.4 (13)

Prednisone

93.9 (31)

NSAIDs

39.4 (13)

Analgesics

36.4 (12)

DMARDs Disease-modifying antirheumatic drugs, NSAIDs Nonsteroidal anti-inflammatory drugs

Patients were middle aged, with female’s predominance. They had a mean (SD) disease duration of 9 (7.4) years. The majority were having anti-CCP-antibodies positive (63,6%) and taking methotrexate (n=32, 97%) and corticosteroids (n=31, 93.9 %).

Among the comorbidities, osteoporosis was the most common (n=11, 33%).

The mean FES-I score was 37.4 ± 15.1 and 69.7% (n = 23) of patients had significant fear of falling.

Correlation analysis

Investigating the relationship between fear of falling and foot pain, impairment and disability, the results demonstrated positive correlations between fear of falling and foot impairment (r=0.66; p<0.0001) and disability (r=0.80; p <0.0001). No correlation was found between fear of falling and foot pain (r = 0.29, p = 0.07).

Evaluating the relationship between fear of falling and disease activity, FES-I was significantly correlated with TJC28 (r = 0.52, p = 0.02), PGA (r=0,56, p=0,01), EGA (r=0,39, p=0,025), HAQ-DI (r = 0.70, p = 0001), DAS28 (r = 0, 38, p = 0.029), CDAI (r = 0.48, p = 0.005) and SDAI (r = 0.52, p = 0.002). No correlation was found between FOF and SJC (r = 0, 18, p = 0.30) Table 2.

Table 2. relationship of foot pain, impairment and disability and disease activity with fear of falling in patients with RA

 

r

p

VAS foot pain

0.29

0.07

LFIST

0.80

<0.0001

LFISIF

0.66

<0.0001

LFISAP

0.83

<0.0001

TJC28

0.52

0.02

SJC28

0.18

0.30

PGA

0,56

0,01

EGA

0,39

0,025

HAQ-DI

0.70

0001

DAS28

0, 38

0.029

CDAI

0.48

0.005

SDAI

0.52

0.002

Factors associated with fear of falling

Table 3 present the results of the multivariate regression analysis using fear of falling as the dependent variable. Foot disability (p ≤0.0001) and HAQ-DI (p =0.017) were  detected to be the apparent independent risk factors affecting variations in FES scores (p ≤0.05).

Table 3. Factors associated with fear of falling in patients with RA (Multivariate analysis)

 

ß

p

IC 95%

DAS28

-0.16

0.186

[-4.64 ; 0.94]

HAQ-DI

0.36

0.017

[1.23 ; 11.80]

LFIST

0.64

0.0001

[0.36 ; 1.06]

Discussion

This study suggest a link between fear of falling, disease activity and foot related disability and impairment. Fear of falling is a problem that affects not only elderly but also patients with RA. The examination of risk factors associated with falls and fear of falling focuses on the elderly. Little is known about factors associated with falls and fear of falling among middle aged and older adults with RA.

Previous studies have reported FOF incidence between 10 and 60% in this population [11-14] and falls incidence between 10 and 50% [4,12,14-18].

In our study, 69.7 % of patients were fearful of falling.  These results are comparable to the findings of Jamison and al and Duyur çakit and al who reported respectively the rate of fear of falling in people with RA as 60% [16] and 66,7 % [19], and higher than Nevitt (50%) [12].

FOF is associated with an increased risk of falls [1,12,16] that may result in avoidance of activities and reduction of physical ability which could increase the risk of future falls.

Fessel and Nevitt examined fear of falling among 570 older adults (aged 50 years and older) with RA [12]. Factors associated with fear of falling included female sex, depressive symptoms, poor physical functioning, minor fall-related injuries, and a greater number of painful joints. Fessel and Nevitt also found that fear of falling motivated many older adults with RA to avoid or modify specific activities [12].

Factors intrinsic to individuals with RA appear to play an important role in fear of falling. Compared with subjects who were not fearful, fearful subjects in our sample were shown to suffer from greater pain intensity due to arthritis, higher levels of disease activity and higher score of foot impairment and disability. In the study of Jamison, fearful patients had more painful joints, longer walk times (which provides evidence of reduced physical fitness), and more comorbid conditions [16].

2021 Copyright OAT. All rights reserv

In another study, the walking time was longer in patients with FOF, and the CASI score, which measures disability and number of tender joints, was higher in subjects with FOF and in those who were classified as fallers [19]. The current results also concur with other study that found that FOF is correlated with disease activity [19].

Several studies have demonstrated that foot problems in patients with rheumatoid arthritis (RA) are highly prevalent, even when classic measures of disease activity suggest clinical remission [20-23]. Despite great advances in disease management, a large majority of patients remain significantly impaired by foot complications [24].

Our findings suggest that fear of falling is significantly correlated to the foot related disability and impairment in patients with RA. These findings are similar to previous studies [12,19,25]; Morpeth et al found that increasing foot disability was associated of fear of falling [26], Furuya and al found the same findings using the Japanese version of the HAQ to assess disability [25].

FOF were not significantly related to older age, which suggest that FOF in patients with RA override the FOF usually associated with age.

No correlation was found between FOF and disease duration, steroid use, foot pain and swollen joints.

The major limitation of this study was a limited sample size, other studies are needed for the evaluation of the reasons of falls, fall risks and FOF associated with foot problems in patients with RA.

In conclusion, this study has demonstrated the importance of the relationship between FOF and disease activity and foot impairment and disability. Others studies are needed to increase the awareness around FOF and foot impairment and disability among practitioners. Because of the risk of the osteoporotic fractures in people with RA is high, the prevention of falls should be the one of the most important objectives of the management of patients with RA.

Authors’ contributions

JB was involved in the study design, performed the statistical analyses and drafted the manuscript. BA was involved in the study coordination and helped to draft the manuscript. IB advised on the statistical analyses and the interpretation of the analyses. ME, YB, SF contributed to the preparation of the data. SR and RB participated in the design and coordination of the study. All authors read and approved the final manuscript.

Acknowledgements

We are grateful to all those who participated in this study

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

Data are available upon request from the corresponding author

Ethics approval and consent to participate

The study protocol was performed in accordance with ethics principles. A subjects’ written consent was obtained. Analysis was conducted on anonymized data.

Funding

None.

Consent for publication

Not applicable.

References

  1. Stanmore EK, Oldham J, Skelton DA, O'Neill T, Pilling M, et al., (2013) Risk factors for falls in adults with rheumatoid arthritis: a prospective study. Arthritis Care Res (Hoboken) 65: 1251-1258. [Crossref]
  2. Keenan MA, Peabody TD, Gronley JK, Perry J (1991) Valgus deformities of the feet and characteristics of gait in patients who have rheumatoid arthritis. J Bone Joint Surg Am 73: 237-247. [Crossref]
  3. Armstrong C1, Swarbrick CM, Pye SR, O'Neill TW (2005) Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis 64: 1602-1604. [Crossref]
  4. Kaz Kaz H, Johnson D, Kerry S, Chinappen U, Tweed K, et al., (2004) Fall-related risk factors and osteoporosis in women withrheumatoid arthritis. Rheumatology (Oxford) 43:1267-1271. [Crossref]
  5. Hakkinen A, Hannonen P, Hakkinen K (1995) Muscle strength in healthy people and in patients suffering from recent-onset inflammatory arthritis. Br J Rheumatol 34: 355-360. [Crossref]
  6. Turner DE, Helliwell PS, Siegel KL, Woodburn J (2008) Biomechanics of the foot in rheumatoid arthritis: identifying abnormal function and the factors associated with localised disease ‘impact’. Clin Biomech 23: 93-100. [Crossref]
  7. Hawker G, Aletaha D, Silman AJ, CohenMD, Bykerk VP, et al., (210) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Care Res 62: 2569.
  8. Helliwell P, Reay N, Gilworth G, Redmond A, Slade A, et al., (2005) Woodburn J. Development of a foot impact scale for rheumatoid arthritis. Arthritis Rheum 53: 418–422. [Crossref]
  9. Hooper L, Bowen CJ, Gates L, Culliford DJ, Ball C, et al., (2012) Prognostic indicators of foot-related disability in patients with rheumatoid arthritis: results of a prospective three-year study. Arthritis Care Res (Hoboken) 64: 1116-1124. [Crossref]
  10. Yardley L, Beyer N, Haeur K, Kempen G, Piot-Ziegler C, et al., (2005) Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 34: 614-619. [Crossref]
  11. Bugdayci D, Paker N, Rezvani A, Kesiktas N, Yilmaz O, et al., (2013) Frequency and predictors for falls in the ambulatory patients with rheumatoid arthritis: a longitudinal prospective study. Rheumatol Int 33: 2523-2527. [Crossref]
  12. Fessel KD, Nevitt MC (1997) Correlates of fear of falling and activity limitation among persons with rheumatoid arthritis. Arthritis Care Res 10: 222-228. [Crossref]
  13. Böhler C, Radner H, Ernst M, Binder A, Stamm T, et al., (2012) Rheumatoid arthritis and falls: the influence of disease activity. Rheumatology (Oxford) 51: 2051-2057. [Crossref]
  14. Yamagiwa K, Iijima S, Furuya T, Ikai T, Inoue E, et al., (2011) Incidence of falls and fear of falling in Japanese patients with rheumatoid arthritis. Mod Rheumatol 21: 51-56.
  15. Oswald AE, Pye SR, O'Neill TW, Bunn D, Gaffney K, et al. (2006) Prevalence and associated factors for falls in women with established inflammatory polyarthritis. J Rheumatol 33: 690-694.
  16. Jamison M, Neuberger GB, Miller PA (2003) Correlates of falls and fear of falling among adults with rheumatoid arthritis. Arthritis Rheum 49: 673-680. [Crossref]
  17. Hayashibara M, Hagino H, Katagiri H, Okano T, Okada J, et al., (2010) Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study. Osteoporos Int 21: 1825-1833. [Crossref]
  18. Smulders E, Schreven C, Weerdesteyn V, van den Hoogen FH, Laan R, et al. (2009) Fall incidence and fall risk factors in people with rheumatoid arthritis. Ann Rheum Dis 68: 1795-1796. [Crossref]
  19. Duyur Cakit B, Nacir B, Erdem HR, Karagoz A, Saracoglu M (2011) Fear of falling, fall risk and disability in patients with rheumatoid arthritis Turk. J Rheumatol 26:217.
  20. Van der Leeden M, Steultjens MP, Van Schaardenburg D, Dekker J (2010) Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study. Arthritis Res Ther 12: R3. [Crossref]
  21. Rome K, Gow PJ, Dalbeth N, Chapman JM (2009) Clinical audit of foot problems in patients with rheumatoid arthritis treated at Counties Manukau District Health Board, Auckland, New Zealand. J Foot Ankle Res 2: 16. [Crossref]
  22. Otter SJ, Lucas K, Springett K, Moore A, Davies K, et al., (2010) Foot pain in rheumatoid arthritis prevalence, risk factors and management: an epidemiological study. Clin Rheumatol 29: 255-271. [Crossref]
  23. Katz PP, Morris A, Yelin EH (2006) Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis 65: 763-769. [Crossref]
  24. Van der Leeden M, Steultjens M, Dekker JH, Prins AP, Dekker J (2007) The relationship of disease duration to foot function, pain and disability in rheumatoid arthritis patients with foot complaints. Clin Exp Rheumatol 25: 275-280. [Crossref]
  25. Furuya T, Yamagiwa K, Ikai T, Inoue E, Taniguchi A, Momohara S, et al. Associated factors for falls and fear of falling in Japanese patients with rheumatoid arthritis. Clin Rheumatol 28: 1325-1330. [Crossref]
  26. Morpeth T, Brenton-Rule A, Carroll M, Frecklington M, Rome K (2016) Fear of falling and foot pain, impairment and disability in rheumatoid arthritis: a case-control study. Clin Rheumatol 35: 887-891. [Crossref]

Editorial Information

Editor-in-Chief

Andras Perl
State University of New York

Article Type

Research Article

Publication history

Received date: September 22, 2017
Accepted date: October 09, 2017
Published date: October 12, 2017

Copyright

© 2017 Bahha J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Bahha J (2017) Fear of falling, foot disability and disease activity in patients with rheumatoid arthritis. Rheumatol Orthop Med, 2: DOI: 10.15761/ROM.1000131

Corresponding author

Jihane Bahha

Department of Rheumatology, EL Ayachi Hospital, Ibn Sina University Hospital, Rabat, El Ayachi hospital, 11000, Sale, Morocco

E-mail : bhuvaneswari.bibleraaj@uhsm.nhs.uk

Table 1 : Clinical characteristics of patients

Parameter

value

Age (years)

49 (24-68)

Female, % (n)

87,9 (29)

Body Mass Index (kg/m2)

26 (16-38)

Disease duration (years), mean (SD)

9 (7.49) (1-36)

Anti-CCP antibodies positive, n (%)

63,6 (21)

Rheumatoid factor positive, n (%)

63,6 (21)

HAQ-DI

1,37 (0.8) (0-2,60)

CDAI

29,9 (13,6) (4-61)

SDAI

31,6 (13,7) (4.4-61.5)

DAS-28

5,5 (1,3) (2,2-7,3)

SJC28

5 (4) (0-17)

TJC28

12 (8) (0-27)

CRP, mg/l

16.7 (18) (0.2-94)

ESR, mm/h

35 (23) (3-90)

PGA, cm

6.2 (2.1) (0-9)

EGA, cm

5.7 (1.7) (0-9)

VAS foot pain

5.5 (2.4) (0-8)

Co-morbid conditions, n (%)

Diabete

9.1 (3)

Heart disease

3 (1)

Hypertension

12.1 (4)

Osteoporosis

33.3 (11)

Renal disease

0

Medications, n (%):

Methotrexate

97 (32)

Biologics

39.4 (13)

Prednisone

93.9 (31)

NSAIDs

39.4 (13)

Analgesics

36.4 (12)

DMARDs Disease-modifying antirheumatic drugs, NSAIDs Nonsteroidal anti-inflammatory drugs

Table 2. relationship of foot pain, impairment and disability and disease activity with fear of falling in patients with RA

 

r

p

VAS foot pain

0.29

0.07

LFIST

0.80

<0.0001

LFISIF

0.66

<0.0001

LFISAP

0.83

<0.0001

TJC28

0.52

0.02

SJC28

0.18

0.30

PGA

0,56

0,01

EGA

0,39

0,025

HAQ-DI

0.70

0001

DAS28

0, 38

0.029

CDAI

0.48

0.005

SDAI

0.52

0.002

Table 3. Factors associated with fear of falling in patients with RA (Multivariate analysis)

 

ß

p

IC 95%

DAS28

-0.16

0.186

[-4.64 ; 0.94]

HAQ-DI

0.36

0.017

[1.23 ; 11.80]

LFIST

0.64

0.0001

[0.36 ; 1.06]